Matrix-degrading metalloproteinases and their roles in joint destruction

Modern Rheumatology

Volumn 10, Issue 3, 2000, Pages 121-128

  Okada, Y ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

A disintegrin and metalloproteinase; Joint destruction; Matrix degradation; Matrix metalloproteinase; Osteoarthritis; Rheumatoid arthritis

Indexed keywords

EID: 84995629928     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.3109/s101650070018     Document Type: Review

References (83)

1. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 1997; 91: 439 – 42.
2. Werb Z, Chin JR. Extracellular matrix remodeling during morphogenesis. Ann N Y Acad Sci 1998; 857: 110 – 8.
3. Eyre DR. The collagens of articular cartilage. Semin Arthritis Rheum 1991; 21: 2 – 11.
4. Yanagishita M. Function of proteoglycans in the extracellular matrix. Acta Pathol Jpn 1993; 43: 283 – 93.
5. Okada Y, Nakanishi I, Kajikawa K. Ultrastructure of the mouse synovial membrane. Development and organization of the extracellular matrix. Arthritis Rheum 1981; 24: 835 – 43.
6. Okada Y, Naka K, Minamoto T, Ueda Y, Oda Y, Nakanishi I, et al. Localization of type VI collagen in the lining cell layer of normal and rheumatoid synovium. Lab Invest 1990; 63: 647 – 56.
7. Woessner JF, Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. Faseb J 1991; 5: 2145 – 54.
8. Black RA, White JM. ADAMs: focus on the protease domain. Curr Opin Cell Biol 1998; 10: 654 – 9.
9. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994; 370: 61 – 5.
10. Will H, Hinzmann B. cDNA sequence and mFtNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment. Eur J Biochem 1995; 231: 602 – 8.
11. Takino T, Sato H, Shinagawa A, Seiki M. Identification of the second membrane-type matrix metalloproteinase (MT- MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family. J Biol Chem 1995; 270: 23013 – 20.
12. Puente XS, Pendas AM, Llano E, Velasco G, Lopez-Otin C. Molecular cloning of a novel membrane-type matrix metallo-proteinase from a human breast carcinoma. Cancer Res 1996; 56: 944 – 9.
13. Pei D. Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MIMP. J Biol Chem 1999; 274: 8925 – 32.
14. Pei D. Leukolysin/MMP25/MT6-MMP: a novel matrix metallo-proteinase specifically expressed in the leukocyte lineage. Cell Res 1999; 9: 291 – 303.
15. Velasco G, Pendas AM, Fueyo A, Knauper V, Murphy G, Lopez-Otin C. Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in repro-ductive tissues and lacking conserved domains in other family members. J Biol Chem 1999; 274: 4570 – 6.
16. Itoh Y, Kajita M, Kinoh H, Mori H, Okada A, Seiki M. Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase. J Biol Chem 1999; 274: 34260 – 6.
17. Pendas AM, Knauper V, Puente XS, Llano E, Mattei MG, Apte S, et al. Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromo-somal location, and tissue distribution. J Biol Chem 1997; 272: 4281 – 6.
18. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996; 97: 761 – 8.
19. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996; 271: 1544 – 50.
20. Fosang AJ, Last K, Knauper V, Murphy G, Neame PJ. Degra-dation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 1996; 380: 17 – 20.
21. Knauper V, Cowell S, Smith B, Lopez-Otin C, O'Shea M, Morris H, et al. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 1997; 272: 7608 – 16.
22. Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanishi I, et al. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur J Biochem 1990; 194: 721 – 30.
23. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem 1992; 267: 21712 – 9.
24. Nagase H, Ogata Y, Suzuki K, Enghild JJ, Salvesen G. Substrate specificities and activation mechanisms of matrix metallopro-teinases. Biochem Soc Trans 1991; 19: 715 – 8.
25. Fosang AJ, Neame PJ, Last K, Hardingham TE, Murphy G, Hamilton JA. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. J Biol Chem 1992; 267: 19470 – 4.
26. Nguyen Q, Murphy G, Hughes CE, Mort JS, Roughley PJ. Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. Biochem J 1993; 295: 595 – 8.
27. Nagase H. Human stromelysins 1 and 2. Methods Enzymol 1995; 248: 449 – 70.
28. Murphy G, Cockett MI, Ward RV, Docherty AJ. Matrix metallo-proteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem J 1991; 277: 277 – 9.
29. Okada Y, Nagase H, Harris ED, Jr. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. J Biol Chem 1986; 261: 14245 – 55.
30. Wu JJ, Lark MW, Chun LE, Eyre DR. Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage. J Biol Chem 1991; 266: 5625 – 8.
31. Nagase H. Activation mechanisms of matrix metalloproteinases. Biol Chem 1997; 378: 151 – 60.
32. Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 1997; 272: 2446 – 51.
33. Pei D, Weiss SJ. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem 1996; 271: 9135 – 40.
34. Fosang AJ, Last K, Fujii Y, Seiki M, Okada Y. Membrane-type 1 MMP (MMP-14) cleaves at three sites in the aggrecan inter- globular domain. FEBS Lett 1998; 430: 186–90.55.
35. Shimada T, Nakamura H, Ohuchi E, Fujii Y, Murakami Y, Sato H, et al. Characterization of a truncated recombinant form of human 57. membrane type 3 matrix metalloproteinase. Eur J Biochem 1999; 262: 907 – 14.
36. Wang X, Yi J, Lei J, Pei D. Expression, purification and 58. characterization of recombinant mouse MT5-MIMP protein products. FEBS Lett 1999; 462: 261 – 6.
37. Imai K, Yokohama Y, Nakanishi I, Ohuchi E, Fujii Y, Nakai N, et 59. al. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties. J Biol Chem 1995; 270: 6691 – 7.
38. Murphy G, Segain JP, O'Shea M, Cockett M, Ioannou C, Lefebvre 60. O, et al. The 28-kDa N-terminal domain of mouse stromelysin-3 has the general properties of a weak metalloproteinase. J Biol Chem 1993; 268: 15435–41.61.
39. Shapiro SD, Kobayashi DK, Ley TJ. Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J Biol Chem 1993; 268: 23824-9. 62.
40. Cossins J, Dudgeon TJ, Catlin G, Gearing AJ, Clements JM. Iden-tification of MMP-18, a putative novel human matrix metallo- proteinase. Biochem Biophys Res Commun 1996; 228: 494–8.63.
41. Llano E, Pendas AM, Knauper V, Sorsa T, Salo T, Salido E, et al. Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry 1997; 36: 15101-8. 64.
42. Nakamura H, Fujii Y, Ohuchi E, Yamamoto E, Okada Y. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases. Eur J Biochem 1998; 253: 67–75.65.
43. Pei D, Weiss SJ. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 1995; 375: 244 – 7.
44. Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M. Activation of a recombinant membrane type 1-matrix metalloproteinase 66. (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 1996; 393: 101 – 4.
45. Maquoi E, Noel A, Frankenne F, Angliker H, Murphy G, Foidart JM. Inhibition of matrix metalloproteinase 2 maturation and HT1080 invasiveness by a synthetic furin inhibitor. FEBS Lett 67. 1998; 424: 262 – 6.
46. Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, van Westrum SS, et al. The TIMP2 membrane type 1 metallo-proteinase “receptor” regulates the concentration and efficient 68. activation of progelatinase A. A kinetic study. J Biol Chem 1998; 273: 871 – 80.
47. Kinoshita T, Sato H, Okada A, Ohuchi E, Imai K, Okada Y, et al. 69. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J Biol Chem 1998; 273: 16098 – 103.
48. Murphy G, Willenbrock F. Tissue inhibitors of matrix metallo- endopeptidases. Methods Enzymol 1995; 248: 496-510. 70.
49. Douglas DA, Shi YE, Sang QA. Computational sequence analysis of the tissue inhibitor of metalloproteinase family. J Protein Chem 1997; 16: 237 – 55.
50. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. Tissue 71. inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997; 74: 111 – 22.
51. Will H, Atkinson SJ, Butler GS, Smith B, Murphy G. The soluble catalytic domain of membrane type 1 matrix metalloproteinase 72. cleaves the propeptide of progelatinase A and initiates auto-proteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem 1996; 271: 17119 – 23.
52. Takizawa M, Ohuchi E, Yamanaka H, Nakamura H, Ikeda E, Ghosh P, Okada Y. Production of tissue inhibitor of metallopro- 73. teinases 3 is selectively enhanced by calcium pentosan polysulfate in human rheumatoid synovial fibroblasts. Arthritis Rheum 2000; 43: 812 – 20.
53. Millichip MI, Dallas DJ, Wu E, Dale S, McKie N. The metallo- 74. disintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro. Biochem Biophys Res Commun 1998; 245: 594 – 8.
54. Lunn CA, Fan X, Dalie B, Miller K, Zavodny PJ, Narula SK, et al. Purification of ADAM 10 from bovine spleen as a TNFalpha convertase. FEBS Lett 1997; 400: 333 – 5.
55. Moss ML, Jin SL, Milla ME, Bickett DM, Burkhart W, Carter HL, et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 1997; 385: 733 – 6.
56. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997; 385: 729 – 33.
57. Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, et al. An essential role for ectodomain shedding in mammalian development. Science 1998; 282: 1281 – 4.
58. Colige A, Li SW, Sieron AL, Nusgens BV, Prockop DJ, Lapiere CM. cDNA cloning and expression of bovine procollagen I N-proteinase: a new member of the superfamily of zinc-metalloproteinases with binding sites for cells and other matrix components. Proc Natl Acad Sci USA 1997; 94: 2374 – 9.
59. Tortorella MD, Burn TC, Pratta MA, Abbaszade I, Hollis JM, Liu R, et al. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 1999; 284: 1664 – 6.
60. Abbaszade I, Liu RQ, Yang F, Rosenfeld SA, Ross OH, Link JR, et al. Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem 1999; 274: 23443 – 50.
61. Kuno K, Terashima Y, Matsushima K. ADAMTS-1 is an active metalloproteinase associated with the extracellular matrix. J Biol Chem 1999; 274: 18821 – 6.
62. Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ, et al. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 1998; 435: 39 – 44.
63. Amer EC, Pratta MA, Trzaskos JM, Decicco CP, Tortorella MD. Generation and characterization of aggrecanase. A soluble, cartilage-derived aggrecan-degrading activity. J Biol Chem 1999; 274: 6594 – 601.
64. Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H. Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann Rheum Dis 1989; 48: 645 – 53.
65. Okada Y, Gonoji Y, Nakanishi I, Nagase H, Hayakawa T. Immunohistochemical demonstration of collagenase and tissue inhibitor of metalloproteinases (TIMP) in synovial lining cells of rheumatoid synovium. Virchows Arch B Cell Pathol 1990; 59: 305 – 12.
66. Hembry RM, Bagga MR, Reynolds JJ, Hamblen DL. Immuno-localisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. Ann Rheum Dis 1995; 54: 25 – 32.
67. Ahrens D, Koch AE, Pope RM, Stein-Picarella M, Niedbala MJ. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum 1996; 39: 1576 – 87.
68. Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, Okada Y. Matrix metalloproteinases and tissue inhibi-tors of meta-lloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis 2000; 59: 455 – 61.
69. Yamanaka H, Makino K, Takizawa M, Nakamura H, Fujimoto N, Moriya H, Nemori R, et al. Expression and tissue localization of membrane-types 1, 2 and 3 matrix metalloproteinases in rheumatoid synovium. Lab Invest 2000; 80: 677 – 87.
70. Delaisse J, Vaes G. Mechanism of mineral solubilization and matrix degradation in osteoclastic bone resorption. In: Rifkin BR, Gay CV, editors. Biology and physiology of the osteodast. Boca Raton: CRC Press; 1992. pp 289 – 314.
71. Okada Y, Naka K, Kawamura K, Matsumoto T, Nakanishi I, Fujimoto N, et al. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase - gelatinase B) in osteoclasts: implications for bone resorption. Lab Invest 1995; 72: 311 – 22.
72. Ueda Y, Imai K, Tsuchiya H, Fujimoto N, Nakanishi I, Katsuda S, et al. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion. Am J Pathol 1996; 148: 611 – 22.
73. Okada Y, Shinmei M, Tanaka O, Naka K, Kimura A, Nakanishi I, et al. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest 1992; 66: 680 – 90.
74. Ohta S, Imai K, Yamashita K, Matsumoto T, Azumano I, Okada Y. Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage. Lab Invest 1998; 78: 79 – 87.
75. Shlopov By, Lie WR, Mainardi CL, Cole AA, Chubinskaya S, Hasty KA. Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum 1997; 40: 2065 – 74.
76. Reboul P, Pelletier JP, Tardif G, Cloutier JM, Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J Clin Invest 1996; 97: 2011 – 9.
77. Mohtai M, Smith RL, Schurman DJ, Tsuji Y, Torti FM, Hutchinson NI, et al. Expression of 92-kD type IV collagenase/ gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1. J Clin Invest 1993; 92: 179 – 85.
78. Imai K, Ohta S, Matsumoto T, Fujimoto N, Sato H, Seiki M, et al. Expression of membrane-type 1 matrix metalloproteinase and ac-tivation of progelatinase A in human osteoarthritic cartilage. Am J Pathol 1997; 151: 245 – 56.
79. McKie N, Edwards T, Dallas DJ, Houghton A, Stringer B, Graham R, et al. Expression of members of a novel mem-brane linked metalloproteinase family (ADAM) in human articular chondrocytes. Biochem Biophys Res Commun 1997; 230: 335 – 9.
80. Chubinskaya S, Cs-Szabo G, Kuettner KE. ADAM- 10 message is expressed in human articular cartilage. J Histochem Cytochem 1998; 46: 723 – 9.
81. Stolow MA, Bauzon DD, Li J, Sedgwick T, Liang VC, Sang QA, Shi YB. Identification and characterization of a novel collagenase in Xenopus laevis: possible roles during frog development. Mol Biol Cell 1996; 7: 1471 – 83.
82. Yang M, Marray MT, Kurkinen M. A novel metalloproteinase gene (XMIMP) encoding vitronectin-like motifs is transiently ex-pressed in Xenopus laevis early embryo development. J Biol Chem 1997; 272: 13527 – 33.
83. Yang M, Kurkinen M. Cloning and characterization of a novel matrix metalloproteinase (MMP), CMMP, from chicken embryo fibroblasts. CMMP, Xenopus XMIMP, and human MMP-19 have a conserved unique cyosteine in the catalytic domain. J Biol Chem 1998; 273: 17893 – 900.